Q&A with Rami Rajab and Inna Nadelwais, Mecomed
Healthcare Innovation Consortium
OCTOBER 24, 2023
We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded.
60 
Let's personalize your content